LDRS — Innovator IBD® ETF Leaders ETF

LDRS Fund Overview

LDRS — Innovator IBD® ETF Leaders ETF is a US ETF managed by Innovator ETFs Trust, categorised as Commodity. ABC INVEST provides holdings, performance, costs, cashflows, risk data, prospectus documents and SEC filings, sourced from SEC filings.

• Type: US ETF
• Manager: Innovator ETFs Trust
• Category: Commodity
• Assets under management: $8.24M
• 1-year return: 22.4%
• Ticker: LDRS
• SEC CIK: 0001415726
• SEC series ID: S000052311
• Share class ID: C000164457

LDRS Investment Objective and Strategy

Innovator IBD® ETF Leaders ETF describes its objective and strategy as follows, from its latest prospectus filed with the SEC by Innovator ETFs Trust.

Investment objective

The Fund seeks to track, before fees and expenses, the performance of the IBD ETF Leaders Index (the Index ).

Principal investment strategy

The Fund will normally invest at least 80% of its net assets (including investment borrowings) in the exchange-traded investment companies ( Underlying Funds ) that comprise the Index. The Fund generally invests in all of the securities comprising the Index in proportion to the weightings of the securities in the Index. The Fund, using an indexing investment approach, attempts to replicate, before fees and expenses, the performance of the Index. Penserra Capital Management LLC, the Funds investment sub-adviser, seeks a correlation of 0.95 or better (before fees and expenses) between the Funds performance and the performance of the Index; a figure of 1.00 would represent perfect correlation. T he Index is a rules-based index owned and developed by Investors Business Daily ( IBD or the Index Provider ) designed to attempt to outperform the broader equity and fixed income markets.

IBD uses proprietary relative strength analysis to select Underlying Funds across various asset classes that are showing market-leading relative strength. The Index may be composed of Underlying Funds that invest in any asset class, including foreign and domestic equity and fixed income securities, and, from time to time, other alternative asset classes. Underlying Funds may invest in securities issued by small-, mid- and large-capitalization companies located in either developed or emerging markets and in securities of any credit quality, including junk securities. The Underlying Funds comprising the Index may be passively or actively managed. The initial universe for the Index is composed of all U.S.-listed exchange-traded funds ( ETFs ) registered under the Investment Company Act of 1940, as amended (the 1940 Act ).

The universe does not include exchange-traded notes, inverse ETFs (ETFs that seek to provide a return that is the exact opposite of an index) with the exception of the ProShares Short S&P 500 ETF, leveraged ETFs (ETFs that seek to amplify the return of an index) and commodity ETFs. The selection universe is then narrowed by excluding Underlying Funds with the following characteristics: 1. Underlying Funds with an average daily trading volume of less than 100,000 over the previous 50 days; 2. Underlying Funds not trading above their average 6-month price; and 3. Underlying Funds with returns less than those of the S&P 500 Index over the course of the previous three months. The remaining Underlying Funds are then ranked according to IBDs relative price strength rating methodology. Relative strength is an investing technique that seeks to determine the strongest performing securities by measuring certain factors, such as a securitys relative performance against the overall market or a securitys relative strength value, which is derived by comparing the rate of increase of the securitys price as compared to that of a benchmark index.

IBD utilizes relative strength to compare an Underlying Funds stock price performance over the last twelve months (with performance over the three most recent months more heavily emphasized) against the over 8,000 foreign and domestic equity securities that comprise IBDs internal database. Each Underlying Fund is ranked according to its relative price performance and assigned a proprietary rating score from 1 (lowest) to 99 (highest). All Underlying Funds with a qualifying rating are included and equally weighted within the Index, subject to the limitations of Section 12(d)(1) of the 1940 Act (for additional information on the limitations of Section 12(d)(1), see Fund InvestmentsExchange-Traded Funds). If less than three Underlying Funds have a qualifying rating, the Index will be composed of Underlying Funds that invest principally in cash or cash equivalents to bring the number of components to three until the next Index reconstitution and rebalance date.

The Index has also been designed to account for the tendency of Underlying Funds to exhibit mean reversion after periods of outsized price appreciation. Mean reversion is the assumption that an Underlying Funds price will tend to move to the average price over time. IBDs proprietary methodology has indicated a level of price growth at which mean reversion is more likely. If the Index exhibits price appreciation up to this level, the Index will be composed of Underlying Funds that principally invest in cash or cash equivalents until the next Index reconstitution and rebalance date. For more information, please see Index Information. Under normal conditions, the Index will be reconstituted and rebalanced on the last trading day of each month. However, if the S&P 500 Index experiences gains of greater than 3% in a given week, the Index will be reconstituted and rebalanced on the final trading day of that week.

As of November 30, 2017, the Index was composed of 26 Underlying Funds. However, given that the Index is generally reconstituted and rebalanced monthly, this may not be a current reflection of the Indexs holdings. The Fund is classified as non-diversified under the 1940 Act. To the extent the Index concentrates ( i.e. , holds 25% or more of its total assets) in the securities of a particular industry or group of industries, the Fund will concentrate its investments to approximately the same extent.

LDRS Performance

Total returns for LDRS (as of 2026-10-01), from SEC filings.

LDRS Risk Information

Risk metrics for LDRS, derived from monthly returns in SEC filings.

• 1-year volatility (annualised): 20.7%

LDRS Costs and Fees

LDRS costs about $107 per $10,000 invested per year in fund expenses.

• Net expense ratio: 1.07%
• Gross expense ratio: 1.07%
• Portfolio turnover: 1079%
• Brokerage commissions: 54.19 bps of average net assets (SEC N-CEN)

LDRS Cashflows

Over the 12 months to 2021-07, Innovator IBD® ETF Leaders ETF had net inflows of $20.69M, from monthly SEC N-PORT filings.

LDRS Debt Constituents

No individual debt constituents are reported in Innovator IBD® ETF Leaders ETF's latest SEC N-PORT filing.

LDRS Prospectus and SEC Filings

Official Innovator IBD® ETF Leaders ETF filings on SEC EDGAR — prospectus, portfolio holdings and annual reports.

• Prospectus (485BPOS) — filed 2021-03-01
• Prospectus (485BPOS) — filed 2020-03-16
• Prospectus (485BPOS) — filed 2019-03-14
• Portfolio holdings (N-PORT) — filed 2021-09-28
• Portfolio holdings (N-PORT) — filed 2021-06-28
• Portfolio holdings (N-PORT) — filed 2021-03-31
• Annual census (N-CEN) — filed 2022-01-14
• Annual census (N-CEN) — filed 2021-01-12

Related Funds

Other Commodity funds tracked on ABC INVEST:

• VanEck Vectors Gold Miners ETF (GDX)
• VanEck Vectors Junior Gold Miners ETF (GDXJ)
• Invesco Optimum Yield Diversified Commodity Strategy No K-1 ETF (PDBC)
• PIMCO CommoditiesPLUS Strategy Fund (PCLAX)
• First Eagle Gold Fund (SGGDX)

Data Sources

ABC INVEST compiles this page from public filings made to the U.S. Securities and Exchange Commission (SEC) through EDGAR: portfolio holdings and monthly cashflows from Form N-PORT, expenses and returns from fund prospectuses (Form 485BPOS) and the SEC DERA Risk/Return Summary data sets, annual data from Form N-CEN, and shareholder reports from Form N-CSR.